Shoichi Murakami

发表

Tricyclic pharmacophore-based molecules as novel integrin αvβ3 antagonists. Part III: Synthesis of potent antagonists with αvβ3/αIIbβ3 dual activity and improved water solubility

M. Ishikawa, K. Ajito, Takashi Watanabe, 2006 .

Tricyclic pharmacophore-based molecules as novel integrin αvβ3 antagonists. Part 2: Synthesis of potent αvβ3/αIIbβ3 dual antagonists

M. Ishikawa, K. Ajito, Mikio Yamamoto, 2006 .

Cross-Talk between Transforming Growth Factor-b and Periostin Can Be Targeted for Pulmonary Fibrosis

Y. Yamaguchi, K. Izuhara, C. Feghali-Bostwick, 2020 .

Periostin plays a critical role in the cell cycle in lung fibroblasts

Y. Yamaguchi, M. Mawatari, K. Izuhara, 2020, Respiratory Research.

A proof of the specificity of kanamycin-ribosomal RNA interaction with designed synthetic analogs and the antibacterial activity.

S. Hattori, K. Ajito, Motoki Kyo, 2005, Bioorganic & medicinal chemistry letters.

Evaluation of four antiseptics using a novel murine norovirus.

T. Oka, N. Takeda, K. Katayama, 2012, Experimental animals.

Discovery of 2-hydroxyarbekacin, a new aminoglycoside antibiotic with reduced nephrotoxicity

Yoshihiko Kobayashi, M. Shibasaki, Yoshiaki Takahashi, 2017, Journal of antibiotics (Tokyo. 1968).

In vitro and in vivo antimicrobial activity of TS2037, a novel aminoglycoside antibiotic

K. Maebashi, T. Usui, D. Ikeda, 2018, The Journal of Antibiotics.

The Cross-Talk Between TGF-β and Periostin Can Be Targeted for Pulmonary Fibrosis.

Y. Yamaguchi, K. Izuhara, C. Feghali-Bostwick, 2020, American journal of respiratory cell and molecular biology.

Tricyclic pharmacophore-based molecules as novel integrin αvβ3 antagonists. Part IV: Preliminary control of αvβ3 selectivity by meta-oriented substitution

M. Kitakaze, M. Ishikawa, K. Ajito, 2006 .

Tricyclic pharmacophore-based molecules as novel integrin αvβ3 antagonists. Part 1: Design and synthesis of a lead compound exhibiting αvβ3/αIIbβ3 dual antagonistic activity

M. Ishikawa, M. Hachisu, K. Ajito, 2006 .